This week, the USPSTF issued its draft guidelines for prostate cancer screening. They propose shifting from task force’s recommendation against routine prostate cancer screening to a recommendation for informed and shared decision-making in which the physician and patient discuss the real risks of harm and the potential for life saving benefit before deciding on screening.
Bits of good news for NIH flickered consistently over the past week.
